偉鴻集團控股(03321.HK)與江西寧宇訂立框架合作協議
格隆匯 7 月 28日丨偉鴻集團控股(03321.HK)發佈公告,2020年7月28日,公司與江西寧宇鋰電製造有限公司訂立框架合作協議,根據框架合作協議,集團擬以最優惠的條件優先向江西寧宇供應硼鋰鉀等資源,同時江西寧宇擬以最優惠的條件優先向集團提供長壽命儲能鋰電池專利及生產技術。
江西寧宇主要從事研究及開發該鋰電池,實益擁有七項於國家知識產權局註冊的獨家專利,該專利有效至2029年。根據江西寧宇的研究及開發報告,該鋰電池除達到使用安全標準及易於和其他儲能配套設備相對接外,該鋰電池壽命(以每天充放電一次計算)長達20年,較現時使用最多及最廣泛的鉛酸電池的壽命多三倍,同時該鋰電池的價格不會比現有電池高超過三分之一。董事會認為與江西寧宇的合作將進一步擴展集團業務範圍及整體收入來源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.